BXM Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

BXM Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$309K	Buy	+5,700	New	+$256K	0.17%	134

Other funds holding ARKG

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Florin Court Capital London, United Kingdom $97M AUM 40.08% 1-Year Est. Return

NTV Asset Management Charleston, West Virginia $1.08B AUM 23.94% 1-Year Est. Return

Midwest Financial Partners Investments St. Cloud, Minnesota $260M AUM 10.89% 1-Year Est. Return

Canal Insurance Company Greenville, South Carolina $426M AUM 30.47% 1-Year Est. Return

Gimbal Financial Carmel, Indiana $172M AUM

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Moran Wealth Management Naples, Florida $3.64B AUM 28.63% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

BXM Wealth's ARKG Position: Q3 2026 in Review

BXM Wealth opened a new position in ARK Genomic Revolution ETF (ARKG) in Q3 2026: 5,700 shares worth $309K. The stake represents 0.17% of the portfolio and ranks #134 among its holdings.

136 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

BXM Wealth held 5,700 shares of ARK Genomic Revolution ETF worth $309K as of Q3 2026.
ARK Genomic Revolution ETF was a new BXM Wealth position in Q3 2026.
ARK Genomic Revolution ETF made up 0.17% of BXM Wealth's portfolio in Q3 2026, its #134 holding.
136 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on BXM Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.